Chapel Hill, NC, United States of America

Seoyoon Cho

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Societe Des Produits Nestle S.a.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Seoyoon Cho: Innovator in Nutritional Compositions

Introduction

Seoyoon Cho is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of nutritional science, particularly in the development of compositions that utilize human milk oligosaccharides.

Latest Patents

Seoyoon Cho holds 1 patent for his invention titled "Compositions comprising human milk oligosaccharides for use in a subject to support night sleep duration." This innovative nutritional composition includes at least one human milk oligosaccharide, such as 3' sialyllactose (3-SL), lacto-N-tetraose (LNT), and core-HMOs. The invention aims to improve total night sleep duration in subjects, showcasing the potential benefits of these compositions.

Career Highlights

Seoyoon Cho is currently employed at Société des Produits Nestlé S.A., a leading company in the food and nutrition industry. His work focuses on advancing nutritional solutions that can enhance health and well-being.

Collaborations

Throughout his career, Seoyoon has collaborated with talented individuals such as Clara Lucia Garcia-Rodenas and Jonas Hauser. These partnerships have contributed to the development of innovative solutions in the field of nutrition.

Conclusion

Seoyoon Cho's work in nutritional compositions highlights the importance of scientific innovation in improving health outcomes. His contributions are paving the way for advancements in nutritional science and enhancing the quality of life for many individuals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…